HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Francisco Pasquau Selected Research

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

2/2017Clinical characteristics and outcome of Spanish patients with ANCA-associated vasculitides: Impact of the vasculitis type, ANCA specificity, and treatment on mortality and morbidity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Francisco Pasquau Research Topics

Disease

3HIV Infections (HIV Infection)
01/2022 - 04/2006
2Infections
01/2012 - 02/2011
1Acquired Immunodeficiency Syndrome (AIDS)
01/2022
1Hemorrhage
02/2017
1Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
02/2017
1Vasculitis (Vasculitides)
02/2017
1Spondylarthritis (Spinal Arthritis)
07/2015
1Rheumatoid Arthritis
07/2015
1Whipple Disease (Whipple's Disease)
07/2015
1Rheumatic Fever (Acute Articular Rheumatism)
07/2015
1Visceral Leishmaniasis (Kala Azar)
12/2014
1Insulin Resistance
05/2004
1Cardiovascular Diseases (Cardiovascular Disease)
05/2004
1Dyslipidemias (Dyslipidemia)
05/2004
1Coinfection
11/2003
1Hepatitis C
11/2003

Drug/Important Bio-Agent (IBA)

2Nevirapine (Viramune)FDA Link
01/2012 - 11/2003
2Protease Inhibitors (Protease Inhibitor)IBA
05/2004 - 11/2003
1Generic DrugsIBA
01/2022
1TabletsIBA
01/2022
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
02/2017
1tocilizumab (atlizumab)FDA Link
07/2015
1Etanercept (Enbrel)FDA Link
07/2015
1Adalimumab (Humira)FDA Link
07/2015
1Rituximab (Mabthera)FDA Link
07/2015
1Infliximab (Remicade)FDA Link
07/2015
1golimumabFDA Link
07/2015
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2015
1AntigensIBA
12/2014
1AntibodiesIBA
12/2014
1Reverse Transcriptase InhibitorsIBA
01/2012
1NucleosidesIBA
01/2012
1efavirenz (Sustiva)FDA Link
11/2003

Therapy/Procedure

4Therapeutics
02/2011 - 11/2003
1Aftercare (After-Treatment)
07/2015
1Highly Active Antiretroviral Therapy (HAART)
05/2004